CVS Health (CVS) Stock Price, News & Analysis

Company Overview

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services. The company also operates a major pharmacy services business (often referred to as Caremark) that manages prescription benefits for employers, insurers and other clients, along with specialty pharmacy and long‑term care services. CVS expanded into the health insurance and managed care market through its acquisition of Aetna, enabling the company to offer health plans and care management alongside traditional pharmacy services.

CVS serves customers primarily across the United States, including U.S. territories, through thousands of retail locations and a national pharmacy services network. The company emphasizes integration of retail, pharmacy benefit management and care delivery to lower costs and improve access to care. Karen S. Lynch serves as president and chief executive officer, leading CVS Health’s efforts to coordinate pharmacy, health plan and in‑person clinical services as part of its broader health care strategy.

Key Stats

• Today's Range: $80.40 to $82.30
• 50-Day Range: $69.98 to $83.72
• 52-Week Range: $58.35 to $85.15
• Volume: 7.30 million shs
• Average Volume: 7.63 million shs
• Market Capitalization: $103.39 billion
• P/E Ratio: 58.46
• Dividend Yield: 3.30%
• Price Target: $94.61
• Consensus Rating: Moderate Buy

CVS Health Stock Analysis - MarketRank™

CVS Health scored higher than 96% of companies evaluated by MarketBeat, and ranked 27th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on no strong buy ratings, 20 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

CVS Health has a consensus price target of $94.61, representing about 17.3% upside from its current price of $80.67.

Amount of Analyst Coverage

CVS Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 14.29%

Earnings Growth

Earnings for CVS Health are expected to grow by 14.29% in the coming year, from $7.14 to $8.16 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CVS Health is 58.46, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.28.

Price to Earnings Ratio vs. Sector

The P/E ratio of CVS Health is 58.46, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.24.

Price to Earnings Growth Ratio

CVS Health has a PEG Ratio of 0.86. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

CVS Health has a P/B Ratio of 1.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.44% of the float of CVS Health has been sold short.

Short Interest Ratio / Days to Cover

CVS Health has a short interest ratio ("days to cover") of 2.52, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CVS Health has recently decreased by 7.73%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

CVS Health pays a meaningful dividend of 3.24%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

CVS Health has only been increasing its dividend for 4 years.

Dividend Coverage

The dividend payout ratio of CVS Health is 192.75%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, CVS Health will have a dividend payout ratio of 32.60% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 1.00

News Sentiment

CVS Health has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 47 news articles for CVS Health this week, compared to 11 articles on an average week.

Search Interest

108 people have searched for CVS on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.

MarketBeat Follows

27 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is an increase of 170% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CVS Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.85% of the stock of CVS Health is held by insiders.

Percentage Held by Institutions

80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CVS Stock Analysis - Frequently Asked Questions

How have CVS shares performed this year?

CVS Health's stock was trading at $79.35 on January 1st, 2026. Since then, CVS stock has increased by 1.7% and is now trading at $80.6720.

How were CVS Health's earnings last quarter?

CVS Health Corporation (NYSE:CVS) announced its earnings results on Tuesday, February, 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The business's revenue for the quarter was up 8.2% on a year-over-year basis.
Read the conference call transcript.

Does CVS Health have any subsidiaries?

The following companies are subsidiaries of CVS Health: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and others.

Who are CVS Health's major shareholders?

CVS Health's top institutional investors include Pzena Investment Management LLC (1.07%), Bank of New York Mellon Corp (0.70%), Sumitomo Mitsui Trust Group Inc. (0.22%) and Swedbank AB (0.18%). Insiders that own company stock include Prem S Shah, Michael F Mahoney, Anne A Finucane, Edward J Ludwig, Guy P Sansone, Guy P Sansone, James David Clark and Steven H Nelson.
View institutional ownership trends.

How do I buy shares of CVS Health?

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Meta Platforms (META), Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Advanced Micro Devices (AMD), Chevron (CVX) and Tesla (TSLA).

Company Calendar

• Last Earnings: 2/10/2026
• Record date for 5/4 Dividend: 4/23/2026
• Ex-Dividend for 5/4 Dividend: 4/23/2026
• Dividend Payable: 5/04/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 5/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Drug Retail
• Current Symbol: NYSE:CVS
• CIK: 64803
• Web: www.cvshealth.com
• Phone: (401) 765-1500
• Fax: 401-762-2137
• Employees: 300,000
• Year Founded: 1963

Price Target and Rating

• Average Price Target for CVS Health: $94.61
• High Price Target: $105.00
• Low Price Target: $72.00
• Potential Upside/Downside: +17.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 24 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.38
• Trailing P/E Ratio: 58.46
• Forward P/E Ratio: 11.30
• P/E Growth: 0.86
• Net Income: $1.77 billion
• Net Margins: 0.44%
• Pretax Margin: 0.53%
• Return on Equity: 11.31%
• Return on Assets: 3.35%

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 0.84
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: $402.07 billion
• Price / Sales: 0.26
• Cash Flow: $14.64 per share
• Price / Cash Flow: 5.51
• Book Value: $59.38 per share
• Price / Book: 1.36

Miscellaneous

• Outstanding Shares: 1,281,600,000
• Free Float: 1,270,710,000
• Market Cap: $103.39 billion
• Optionable: Optionable
• Beta: 0.60